OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use

PURPOSE: To evaluate OC-01 [varenicline solution nasal spray (VNS)] tear production and symptom outcomes in patients with dry eye disease by age, gender, race, ethnicity, and artificial tear use status. PATIENTS AND METHODS: Adults ≥22 years of age diagnosed with dry eye disease, with Ocular Surface...

Descripción completa

Detalles Bibliográficos
Autores principales: Epitropoulos, Alice T, Daya, Sheraz M, Matossian, Cynthia, Kabat, Alan G, Blemker, Gretchen, Striffler, Kristen, Hendrix, Laura, Macsai, Marian, Gibson, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556276/
https://www.ncbi.nlm.nih.gov/pubmed/36249445
http://dx.doi.org/10.2147/OPTH.S383091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556276/
https://www.ncbi.nlm.nih.gov/pubmed/36249445
http://dx.doi.org/10.2147/OPTH.S383091

Ejemplares similares